Consolidated Statement of Cash Flows (Successor Basis) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2021
Cash flows from operating activities:
Net income	$ 4,555,975		$ 9,480,134	$ (9,667,137)
Adjustments to reconcile net income to net cash from operating activities:
Net unrealized gain on equity securities	193,298		(2,961,335)
Net income from equity method investments at fair value			(1,960,012)
Net realized gain on investments	(3,750,371)	$ 26	(4,353,191)	(1,016,326)
Straight - line rent			(383,143)
Depreciation and amortization			2,078,694
Amortization of deferred financing costs			6,150	342,015
Accretion of market lease and other intangibles, net			(84,758)
Changes in assets and liabilities:
Investment income, rent and other receivables			393,253	(447,398)
Due from related entities			(10,000)	(150,866)
Prepaid expenses and other assets			(530,823)
Accounts payable and accrued liabilities			348,827	(48,028)
Deferred rent and other liabilities			133,544
Due to related entities			96,351	(40,083)
Net cash from operating activities			2,253,691	3,142,438
Cash flows from investing activities:
Proceeds from sale of investments			23,299,708
Investments in real estate assets			(21,777,799)
Purchase of investments			(3,232,548)
Return on capital distributions			4,204,209
Net cash from investing activities			2,493,570	1,932,088
Cash flows from financing activities:
Proceeds from mortgage notes payable			15,000,000
Payments on mortgage notes payable			(708,824)
Dividend to stockholders			(1,205,172)
Payment of deferred financing costs			(784,327)
Proceeds from issuance of preferred stock			88,000		$ 88,000
Payment of selling commissions and fees			(431,424)	(9,107)
Contributions by non-controlling interests holders			856,364
Distributions to non-controlling interests holders			(5,350)
Redemption of common stock			(55,188)
Capital pending acceptance			73,000	(87,739)
Net cash from financing activities			12,827,079	121,593
Net increase in cash and restricted cash equivalents			17,574,340	5,196,119
Cash, cash equivalents and restricted cash at beginning of the period			7,753,553	8,957,393	8,957,393
Cash, cash equivalents and restricted cash at end of the period	25,327,893	14,153,512	25,327,893	14,153,512	7,753,553
Cash at end of the period	10,866,920	12,539,943	10,866,920	12,539,943	4,833,848
Restricted cash at end of the period	$ 14,460,973	$ 1,613,569	14,460,973	$ 1,613,569	$ 2,919,705
Supplemental disclosure of non-cash financing activities and other cash flow information
Issuance of common stock through reinvestment of dividends			526,310
Cash paid for interest			$ 832,849